DAP:ETR
Danaher Corp
€210.60
arrow_upward
+0.81%(+1.70) 1D
Nov 16, 5:35:42 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DAP...
Open
€211.80
High
€213.30
Low
€209.80
Mkt. cap
161.75B
Avg. vol.
540.00
Volume
87.00
52-wk high
€214.50
52-wk low
€138.20
No. of employees
59K
Open
€211.80
High
€213.30
Low
€209.80
Mkt. cap
161.75B
Avg. vol.
540.00
Volume
87.00
52-wk high
€214.50
52-wk low
€138.20
No. of employees
59K
News stories
From web sources and news partners
TradingView
·
1 hour ago
S&P 500, Dow, Nasdaq End Lower As Investors Hold Back Ahead Of Nvidia Earnings, Anthropic IPO This Week — NVDA, TSLA, ANT In Focus
BigGo Finance
·
11 hours ago
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
ChartMill
·
5 hours ago
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
www.tokenpost.com
·
57 minutes ago
Nasdaq Composite Falls 2.49% as Tempus AI Leads AI Stock Declines
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp